Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3

Brain Research

Volumn 633, Issue 1-2, 1994, Pages 326-330

  Siuciak, Judith A ^a   Altar, Anthony ^a   Wiegand, Stanley J ^a   Lindsay, Ronald M ^a  

^a REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

Analgesia; Brain derived neurotrophic factor; Naloxone; Nerve growth factor; Neurotrophin 3; Periaqueductal gray; Serotonin; Spinal cord

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; NALOXONE; NERVE GROWTH FACTOR; NEUROTROPHIN 3; SEROTONIN;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SPINAL CORD;

ANALGESICS; ANIMAL; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMISTRY; HYDROXYINDOLEACETIC ACID; INJECTIONS; MALE; MESENCEPHALON; NALOXONE; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUROTROPHIN 3; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SPINAL CORD;

EID: 0027954314     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(94)91556-3     Document Type: Article

References (43)

1. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture
2. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo
3. 125I] neurotrophin-3 binding to mammalian brain
4. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry
5. Evidence that an excitatory connection between the periaqueductal gray and nucleus raphe magnus mediates stimulation produced by analgesia
6. The sites of origin brain stem neurotensin and serotonin projections to the rodent nucleus raphe magnus
7. The periaqueductal gray-raphe magnus projection contains somatostatin, neurotensin and serotonin but not cholecystokinin
8. The periaqueductal gray projections to the rat spinal trigeminal, raphe magnus, gigantocellular pars alpha and paragigantocellular nuclei arise from separate neurons
9. Evidence for depressant 5-HT1-like receptors on rat brainstem neurones
10. Role of the nucleus raphe magnus in opiate analgesia as studied by the microinjection technique in the rat
11. Simultaneous measurement of monoamines, metabolites and amino acids in brain tissue and microdialysis
12. Control systems for nociceptive afferent processing: the descending inhibitory pathways
13. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
14. Effects of BDNF and NT-3 on dopaminergic and GABAergic neurons in rat ventral mesencephalic cultures
15. Cultured hippocampal neurons show responses to BDNF, NT-3 and NT-4, but not NGF
16. Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brainstem sites
17. Examination of spinal monoamine receptors through which brainstem opiate-sensitive systems act in the rat
18. Comparison of the antinociceptive effect of morphine and glutamate at coincidental sites in the periaqueductal gray and medial medulla in rats
19. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by NGF, bFGF, EGF, insulin and the insulin-like growth factors I and II
20. BDNF administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult brain
21. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat
22. The role of neurotrophic factors in functional maintenance of mature sensory neurons
23. Brain-derived Neurotrophic Factor: An NGF-related neurotrophin
24. The effect of modification of 5-hydroxytryptamine function in nucleus raphe magnus on nociceptive threshold
25. Spinal projections from the periaqueductal grey and dorsal raphe in the rat, and cat and monkey
26. Analgesia from electrical stimulation in the brainstem of the rat
27. The peptidergic organization of the cat periaqueductal gray. I. The distribution of immunoreactive enkephalin-containing neurons and terminals
28. The peptidergic organization of the cat periaqueductal gray. II. The distribution of immunoreactive substance P and vasoactive intestinal polypeptide
29. Regulation of neuropeptide expression in cultured cerebral cortical neurons by brain-derived neurotrophic factor
30. Physiologic evidence for a projection from periaqueductal gray to nucleus raphe magnus in the rat
31. In vitro release of 5-hydroxytryptamine and gamma-aminobutyric acid from rat periaqueductal grey and raphe dorsalis region produced by morphine or an enkephalin analogue
32. Serotonin and nociception
33. The 1988 Merck Frost Award. The role of ascending and descending noradrenergic and serotonergic pathways in opioid and non-opioid antinociception as revealed by lesion studies
34. Morphine analgesia and the bulbospinal serotonergic system: increase in concentration of 5-hydroxyindoleacetic acid in the rat spinal cord with analgesics
35. Tolerance to morphine microinjections in the periaqueductal gray (PAG) induces tolerance to systemic, but not intrathecal morphine
36. Evidence for periaqueductal cholecystokinin-substance P neurons projecting to the spinal cord
37. Physiology of nerve growth factor
38. Glutamate-induced analgesia: blockade and potentiation by naloxone
39. Analgesia, development and 5-hydroxytryptamine turnover in the rat after cereberal and systemic adminstration of morphine
40. Autoradiographic and electrophysiological evidence for excitatory amino acid transmission in the periaqueductal gray projection to nucleus raphe magnus in the rat
41. Microinjection of morphine into the periaqueductal gray evokes the release of serotonin form spinal cord